VALNEVA SE - ADR (VALN) Fundamental Analysis & Valuation

NASDAQ:VALN • US92025Y1038

Current stock price

10.495 USD
-0.7 (-6.21%)
Last:

This VALN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. VALN Profitability Analysis

1.1 Basic Checks

  • In the past year VALN has reported negative net income.
  • VALN had a negative operating cash flow in the past year.
  • VALN had negative earnings in each of the past 5 years.
  • In multiple years VALN reported negative operating cash flow during the last 5 years.
VALN Yearly Net Income VS EBIT VS OCF VS FCFVALN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M

1.2 Ratios

  • With a decent Return On Assets value of -26.86%, VALN is doing good in the industry, outperforming 68.53% of the companies in the same industry.
  • VALN has a Return On Equity (-80.02%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -26.86%
ROE -80.02%
ROIC N/A
ROA(3y)-15.85%
ROA(5y)-14.17%
ROE(3y)-50.34%
ROE(5y)-55.45%
ROIC(3y)N/A
ROIC(5y)N/A
VALN Yearly ROA, ROE, ROICVALN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

  • With a decent Gross Margin value of 46.53%, VALN is doing good in the industry, outperforming 74.32% of the companies in the same industry.
  • In the last couple of years the Gross Margin of VALN has declined.
  • The Profit Margin and Operating Margin are not available for VALN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 46.53%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.2%
GM growth 5Y-7.06%
VALN Yearly Profit, Operating, Gross MarginsVALN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 -60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. VALN Health Analysis

2.1 Basic Checks

  • VALN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • VALN has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, VALN has more shares outstanding
  • VALN has a better debt/assets ratio than last year.
VALN Yearly Shares OutstandingVALN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
VALN Yearly Total Debt VS Total AssetsVALN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • VALN has an Altman-Z score of 0.24. This is a bad value and indicates that VALN is not financially healthy and even has some risk of bankruptcy.
  • With a decent Altman-Z score value of 0.24, VALN is doing good in the industry, outperforming 60.23% of the companies in the same industry.
  • A Debt/Equity ratio of 0.89 indicates that VALN is somewhat dependend on debt financing.
  • The Debt to Equity ratio of VALN (0.89) is worse than 74.13% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF N/A
Altman-Z 0.24
ROIC/WACCN/A
WACC8.03%
VALN Yearly LT Debt VS Equity VS FCFVALN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M

2.3 Liquidity

  • VALN has a Current Ratio of 1.78. This is a normal value and indicates that VALN is financially healthy and should not expect problems in meeting its short term obligations.
  • VALN has a Current ratio of 1.78. This is in the lower half of the industry: VALN underperforms 78.76% of its industry peers.
  • A Quick Ratio of 1.36 indicates that VALN should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.36, VALN is doing worse than 82.82% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.78
Quick Ratio 1.36
VALN Yearly Current Assets VS Current LiabilitesVALN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. VALN Growth Analysis

3.1 Past

  • The earnings per share for VALN have decreased strongly by -1180.00% in the last year.
  • Looking at the last year, VALN shows a quite strong growth in Revenue. The Revenue has grown by 19.89% in the last year.
  • Measured over the past years, VALN shows a small growth in Revenue. The Revenue has been growing by 6.09% on average per year.
EPS 1Y (TTM)-1180%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-271.43%
Revenue 1Y (TTM)19.89%
Revenue growth 3Y-21.31%
Revenue growth 5Y6.09%
Sales Q2Q%-35.76%

3.2 Future

  • VALN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 31.23% yearly.
  • Based on estimates for the next years, VALN will show a quite strong growth in Revenue. The Revenue will grow by 14.36% on average per year.
EPS Next Y-619.02%
EPS Next 2Y-113.75%
EPS Next 3Y105.69%
EPS Next 5Y31.23%
Revenue Next Year-7.65%
Revenue Next 2Y-1.79%
Revenue Next 3Y22.81%
Revenue Next 5Y14.36%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
VALN Yearly Revenue VS EstimatesVALN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 100M 200M 300M 400M
VALN Yearly EPS VS EstimatesVALN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 1 -1 2 -2

More info and screens

Find the best growth stocksShow best growing peers

1

4. VALN Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for VALN. In the last year negative earnings were reported.
  • Also next year VALN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VALN Price Earnings VS Forward Price EarningsVALN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VALN Per share dataVALN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3

4.3 Compensation for Growth

  • VALN's earnings are expected to grow with 105.69% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-113.75%
EPS Next 3Y105.69%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. VALN Dividend Analysis

5.1 Amount

  • VALN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

VALN Fundamentals: All Metrics, Ratios and Statistics

VALNEVA SE - ADR

NASDAQ:VALN (3/19/2026, 8:00:02 PM)

10.495

-0.7 (-6.21%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-16
Earnings (Next)05-07
Inst Owners24.55%
Inst Owner Change-0.87%
Ins Owners0.21%
Ins Owner ChangeN/A
Market Cap911.77M
Revenue(TTM)274.97M
Net Income(TTM)-120.41M
Analysts81.82
Price Target17.37 (65.51%)
Short Float %0.18%
Short Ratio8.11
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-17%
Min EPS beat(2)-90.69%
Max EPS beat(2)56.68%
EPS beat(4)2
Avg EPS beat(4)-21.59%
Min EPS beat(4)-115.24%
Max EPS beat(4)62.87%
EPS beat(8)4
Avg EPS beat(8)-5.97%
EPS beat(12)6
Avg EPS beat(12)-29.73%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-5.23%
Min Revenue beat(2)-26.86%
Max Revenue beat(2)16.4%
Revenue beat(4)2
Avg Revenue beat(4)2.94%
Min Revenue beat(4)-26.86%
Max Revenue beat(4)26.97%
Revenue beat(8)3
Avg Revenue beat(8)-2.55%
Revenue beat(12)7
Avg Revenue beat(12)17.96%
Revenue beat(16)9
Avg Revenue beat(16)99.55%
PT rev (1m)1.95%
PT rev (3m)3%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-12.03%
EPS NY rev (1m)-1.7%
EPS NY rev (3m)-8.86%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-8.13%
Revenue NY rev (1m)-1.02%
Revenue NY rev (3m)-2.38%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.88
P/FCF N/A
P/OCF N/A
P/B 5.27
P/tB 6.22
EV/EBITDA N/A
EPS(TTM)-1.53
EYN/A
EPS(NY)-0.77
Fwd EYN/A
FCF(TTM)-0.24
FCFYN/A
OCF(TTM)-0.24
OCFYN/A
SpS3.64
BVpS1.99
TBVpS1.69
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -26.86%
ROE -80.02%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 46.53%
FCFM N/A
ROA(3y)-15.85%
ROA(5y)-14.17%
ROE(3y)-50.34%
ROE(5y)-55.45%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.2%
GM growth 5Y-7.06%
F-Score4
Asset Turnover0.61
Health
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 3.08%
Cap/Sales 0.22%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.78
Quick Ratio 1.36
Altman-Z 0.24
F-Score4
WACC8.03%
ROIC/WACCN/A
Cap/Depr(3y)101.58%
Cap/Depr(5y)231.17%
Cap/Sales(3y)9.04%
Cap/Sales(5y)14.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1180%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-271.43%
EPS Next Y-619.02%
EPS Next 2Y-113.75%
EPS Next 3Y105.69%
EPS Next 5Y31.23%
Revenue 1Y (TTM)19.89%
Revenue growth 3Y-21.31%
Revenue growth 5Y6.09%
Sales Q2Q%-35.76%
Revenue Next Year-7.65%
Revenue Next 2Y-1.79%
Revenue Next 3Y22.81%
Revenue Next 5Y14.36%
EBIT growth 1Y-162.67%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-276.1%
EBIT Next 3Y56.77%
EBIT Next 5Y7.59%
FCF growth 1Y91.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y90.46%
OCF growth 3YN/A
OCF growth 5YN/A

VALNEVA SE - ADR / VALN Fundamental Analysis FAQ

What is the fundamental rating for VALN stock?

ChartMill assigns a fundamental rating of 2 / 10 to VALN.


What is the valuation status for VALN stock?

ChartMill assigns a valuation rating of 1 / 10 to VALNEVA SE - ADR (VALN). This can be considered as Overvalued.


What is the profitability of VALN stock?

VALNEVA SE - ADR (VALN) has a profitability rating of 2 / 10.


How financially healthy is VALNEVA SE - ADR?

The financial health rating of VALNEVA SE - ADR (VALN) is 2 / 10.